or Try an Advanced Search...

    Technical Analysis for VIRI - Virios Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 0.47 3.01% 0.01
    VIRI closed up 3.01 percent on Friday, April 26, 2024, on 12 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical VIRI trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Inside Day Range Contraction 3.01%
    Wide Bands Range Expansion 3.01%
    20 DMA Resistance Bearish 10.42%
    Shooting Star Candlestick Bearish 10.42%
    Wide Bands Range Expansion 10.42%
    Oversold Stochastic Weakness 10.42%
    Stochastic Buy Signal Bullish 8.93%
    Wide Bands Range Expansion 8.93%
    Oversold Stochastic Weakness 8.93%
    Older End-of-Day Signals for VIRI ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 7 hours ago
    60 Minute Opening Range Breakout about 7 hours ago
    Rose Above Previous Day's High about 7 hours ago
    Up 3% about 7 hours ago
    Up 2% about 7 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VIRI Chart by TradingView
    Basic chart:

    Profile

    Virios Therapeutics, LLC, a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, LLC in July 2020. Virios Therapeutics, LLC was founded in 2012 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Rheumatology Fibromyalgia Antiviral Therapies

    Is VIRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 26 Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
    Mar 1 Virios Therapeutics reports Q4 results
    Feb 29 Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
    Feb 28 Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
    Feb 7 VIRI: Moving IMC-2 into Phase 2 Program in Long COVID
    Jan 22 Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge
    Jan 22 Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
    Jan 9 Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Jan 2 Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
    Nov 14 Virios Therapeutics, Inc. (NASDAQ:VIRI) Q3 2023 Earnings Call Transcript
    See more VIRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.42
    52 Week Low 0.279
    Average Volume 339,735
    200-Day Moving Average 0.78
    50-Day Moving Average 0.41
    20-Day Moving Average 0.47
    10-Day Moving Average 0.45
    Average True Range 0.06
    RSI (14) 54.55
    ADX 17.93
    +DI 19.50
    -DI 15.80
    Chandelier Exit (Long, 3 ATRs) 0.41
    Chandelier Exit (Short, 3 ATRs) 0.57
    Upper Bollinger Bands 0.54
    Lower Bollinger Band 0.39
    Percent B (%b) 0.5
    BandWidth 31.91
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0041
    Fundamentals Value
    Market Cap 9.04 Million
    Num Shares 19.3 Million
    EPS -0.16
    Price-to-Earnings (P/E) Ratio -2.93
    Price-to-Sales 0.00
    Price-to-Book 1.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.52
    Resistance 3 (R3) 0.52 0.50 0.51
    Resistance 2 (R2) 0.50 0.48 0.50 0.51
    Resistance 1 (R1) 0.48 0.47 0.49 0.49 0.51
    Pivot Point 0.46 0.46 0.46 0.46 0.46
    Support 1 (S1) 0.45 0.45 0.45 0.45 0.43
    Support 2 (S2) 0.43 0.44 0.43 0.43
    Support 3 (S3) 0.41 0.43 0.43
    Support 4 (S4) 0.42